Regulated function of the prolyl-4-hydroxylase domain (PHD) oxygen sensor proteins

Antioxidants and Redox Signaling

Volumn 9, Issue 9, 2007, Pages 1329-1338

  Nytko, Katarzyna J ^a   Spielmann, Patrick ^a   Camenisch, Gieri ^a   Wenger, Roland H ^a   Stiehl, Daniel P ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASCORBIC ACID; COBALT; COPPER; FERROUS ION; GALLIC ACID; GALLIC ACID PROPYL ESTER; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON; NICKEL; OXYGEN; PEPTIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROLYL 4 HYDROXYLASE 1; PROLYL 4 HYDROXYLASE 2; PROLYL 4 HYDROXYLASE 3; PROTEASOME; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VON HIPPEL LINDAU PROTEIN;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL FREE SYSTEM; CITRIC ACID CYCLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; HYDROXYLATION; HYPOXIA; IN VITRO STUDY; NONHUMAN; OXYGEN SENSING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; ASCORBIC ACID; CHO CELLS; CRICETINAE; CRICETULUS; GENES, REPORTER; IRON; KINETICS; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PROCOLLAGEN-PROLINE DIOXYGENASE;

EID: 34547915996     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1683     Document Type: Article

References (60)

1. Abu-Farha M, Niles J, and Willmore WG. Erythroid-specific 5-aminolevulinate synthase protein is stabilized by low oxygen and proteasomal inhibition. Biochem Cell Biol 83: 620-630, 2005.
2. Appelhoff RJ, Tian YM, Raval RR, Turley H, Harris AL, Pugh CW, Ratcliffe PJ, and Gleadle JM. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 279: 38458-38465, 2004.
3. Aprelikova O, Chandramouli GV, Wood M, Vasselli JR, Riss J, Maranchie JK, Linehan WM, and Barrett JC. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J Cell Biochem 92: 491-501, 2004.
4. Baek JH, Mahon PC, Oh J, Kelly B, Krishnamachary B, Pearson M, Chan DA, Giaccia AJ, and Semenza GL. OS-9 interacts with hypoxia-inducible factor 1α and prolyl hydroxylases to promote oxygen-dependent degradation of HIF-1α. Mol Cell 17: 503-512, 2005.
5. Barth S, Nesper J, Hasgall PA, Wirthner R, Nytko KJ, Edlich F, Katschinski DM, Stiehl DP, Wenger RH, and Camenisch G. The peptidyl-prolyl cis/trans isomerase FKBP38 determines HIF prolyl-4-hydroxylase PHD2 protein stability. Mol Cell Biol 27: 3758-3768, 2007.
6. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, and Pouysségur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J 22: 4082-4090, 2003.
7. Bruick RK and McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294: 1337-1340, 2001.
8. Cioffi CL, Liu XQ, Kosinski PA, Garay M, and Bowen BR. Differential regulation of HIF-1α prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem Biophys Res Commun 303: 947-953, 2003.
9. Cockman ME, Lancaster DE, Stolze IP, Hewitson KS, McDonough MA, Coleman ML, Coles CH, Yu X, Hay RT, Ley SC, Pugh CW, Oldham NJ, Masson N, Schofield CJ, and Ratcliffe PJ. Posttranslational hydroxylation of ankyrin repeats in IκB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc Natl Acad Sci USA 103: 14767-14772, 2006.
10. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouysségur J, and Taylor CT. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc Natl Acad Sci USA 103: 18154-18159, 2006.
11. D'Angelo G, Duplan E, Boyer N, Vigne P, and Frelin C. Hypoxia up-regulates prolyl hydroxylase activity: a feedback mechanism that limits HIF-1 responses during reoxygenation. J Biol Chem 278: 38183-38187, 2003.
12. Dalgard CL, Lu H, Mohyeldin A, and Verma A. Endogenous 2-oxoacids differentially regulate expression of oxygen sensors. Biochem J 380: 419-424, 2004.
13. del Peso L, Castellanos MC, Temes E, Martin-Puig S, Cuevas Y, Olmos G, and Landázuri MO. The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J Biol Chem 278: 48690-48695, 2003.
14. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, Tian YM, Masson N, Hamilton DL, Jaakkola P, Barstead R, Hodgkin J, Maxwell PH, Pugh CW, Schofield CJ, and Ratcliffe PJ. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107: 43-54, 2001.
15. Gerald D, Berra E, Frapart YM, Chan DA, Giaccia AJ, Mansuy D, Pouysségur J, Yaniv M, and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118: 781-794, 2004.
16. Hewitson KS, Liénard BM, McDonough MA, Clifton I, Butler D, Soares AS, Oldham NJ, McNeill LA, and Schofield CJ. Structural and mechanistic studies on the inhibition of the HIF hydroxylases by tricarboxylic acid cycle intermediates. J Biol Chem: 2006.
17. Hirsilä M, Koivunen P, Günzler V, Kivirikko KI, and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J Biol Chem 278: 30772-30780, 2003.
18. Hirsilä M, Koivunen P, Xu L, Seeley T, Kivirikko KI, and Myllyharju J. Effect of desferoxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J 19: 1308-1310, 2005.
19. Hopfer U, Hopfer H, Jablonski K, Stahl RA, and Wolf G. The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J Biol Chem 281: 8645-8655, 2006.
20. Isaacs JS, Jung YJ, Mole DR, Lee S, Torres-Cabala C, Chung YL, Merino M, Trepel J, Zbar B, Toro J, Ratcliffe PJ, Linehan WM, and Neckers L. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8: 143-153, 2005.
21. Jewell UR, Kvietikova I, Scheid A, Bauer C, Wenger RH, and Gassmann M. Induction of HIF-1α in response to hypoxia is instantaneous. FASEB J 15: 1312-1314, 2001.
22. Jones DT, Trowbridge IS, and Harris AL. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate. Cancer Res 66: 2749-2756, 2006.
23. Karaczyn A, Ivanov S, Reynolds M, Zhitkovich A, Kasprzak KS, and Salnikow K. Ascorbate depletion mediates up-regulation of hypoxia-associated proteins by cell density and nickel. J Cell Biochem 97: 1025-1035, 2006.
24. Knowles HJ, Mole DR, Ratcliffe PJ, and Harris AL. Normoxic stabilization of hypoxia-inducible factor-1α by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res 66: 2600-2607, 2006.
25. Knowles HJ, Raval RR, Harris AL, and Ratcliffe PJ. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res 63: 1764-1768, 2003.
26. Koivunen P, Hirsilä M, Remes AM, Hassinen IE, Kivirikko KI, and Myllyharju J. Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF. J Biol Chem 282: 4524-4532, 2007.
27. Kuznetsova AV, Meller J, Schnell PO, Nash JA, Ignacak ML, Sanchez Y, Conaway JW, Conaway RC, and Czyzyk-Krzeska MF. von Hippel-Lindau protein binds hyperphosphorylated large subunit of RNA polymerase II through a proline hydroxylation motif and targets it for ubiquitination. Proc Natl Acad Sci USA 100: 2706-2711, 2003.
28. Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, and Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16: 1466-1471, 2002.
29. Linden T, Katschinski DM, Eckhardt K, Scheid A, Pagel H, and Wenger RH. The antimycotic ciclopirox olamine induces HIF-1α stability, VEGF expression, and angiogenesis. FASEB J 17: 761-763, 2003.
30. Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, and Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280: 41928-41939, 2005.
31. Mahon PC, Hirota K, and Semenza GL. FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev 15: 2675-2686, 2001.
32. Martin F, Linden T, Katschinski DM, Oehme F, Flamme I, Mukhopadhyay CK, Eckhardt K, Troger J, Barth S, Camenisch G, and Wenger RH. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 105: 4613-4619, 2005.
33. Marxsen JH, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T, Jeikmann W, Jaakkola P, and Metzen E. Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4-hydroxylases. Biochem J 381: 761-767, 2004.
34. Masson N, Appelhoff RJ, Tuckerman JR, Tian YM, Demol H, Puype M, Vandekerckhove J, Ratcliffe PJ, and Pugh CW. The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett 570: 166-170, 2004.
35. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
36. McNeill LA, Flashman E, Buck MR, Hewitson KS, Clifton IJ, Jeschke G, Claridge TD, Ehrismann D, Oldham NJ, and Schofield CJ. Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol Biosys 1: 321-324, 2005.
37. Metzen E, Stiehl DP, Doege K, Marxsen JH, Hellwig-Bürgel T, and Jelkmann W. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem J 387: 711-717, 2005.
38. Myllylä R, Majamaa K, Günzler V, Hanauske-Abel HM, and Kivirikko KI. Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase. J Biol Chem 259: 5403-5405, 1984.
39. Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, Kadoya T, Erdjument-Bromage H, Tempst P, Frappell PB, Bowtell DD, and Ronai Z. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 117: 941-952, 2004.
40. Oehme F, Ellinghaus P, Kolkhof P, Smith TJ, Ramakrishnan S, Hutter J, Schramm M, and Flamme I. Overexpression of PH-4, a novel putative proline 4-hydroxylase, modulates activity of hypoxia-inducible transcription factors. Biochem Biophys Res Commun 296: 343-349, 2002.
41. Oehme F, Jonghaus W, Narouz-Ott L, Huetter J, and Flamme I. A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity. Anal Biochem 330: 74-80, 2004.
42. Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, Landázuri MO, and Del Peso L. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 390: 189-197, 2005.
43. Pollard PJ, Brière JJ, Alam NA, Barwell J, Barclay E, Wortham NC, Hunt T, Mitchell M, Olpin S, Moat SJ, Hargreaves IP, Heales SJ, Chung YL, Griffiths JR, Dalgleish A, McGrath JA, Gleeson MJ, Hodgson SV, Poulsom R, Rustin P, and Tomlinson IP. Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14: 2231-2239, 2005.
44. Pouysségur J, Dayan F, and Mazure NM. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441: 437-443, 2006.
45. 2 formation. FASEB J 14: 1953-1964, 2000.
46. Salnikow K, Donald SP, Bruick RK, Zhitkovich A, Phang JM, and Kasprzak KS. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J Biol Chem 279: 40337-40344, 2004.
47. Schofield CJ and Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354, 2004.
48. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB, and Gottlieb E. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7: 77-85, 2005.
49. Stait SE and Leake DS. The effects of ascorbate and dehydroascorbate on the oxidation of low-density lipoprotein. Biochem J 320: 373-381, 1996.
50. Stiehl DP, Wirthner R, Koditz J, Spielmann P, Camenisch G, and Wenger RH. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. J Biol Chem 281: 23482-23491, 2006.
51. Takeda K, Ho VC, Takeda H, Duan LJ, Nagy A, and Fong GH. Placental but not heart defects are associated with elevated hypoxia-inducible factor α levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell Biol 26: 8336-8346, 2006.
52. Thomas R and Kim MH. Epigallocatechin gallate inhibits HIF-1α degradation in prostate cancer cells. Biochem Biophys Res Commun 334: 543-548, 2005.
53. Tsukiyama F, Nakai Y, Yoshida M, Tokuhara T, Hirota K, Sakai A, Hayashi H, and Katsumata T. Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase. Biochem Biophys Res Commun 351: 234-239, 2006.
54. Wang J, Chen G, Muckenthaler M, Galy B, Hentze MW, and Pantopoulos K. Iron-mediated degradation of IRP2, an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol Cell Biol 24: 954-965, 2004.
55. Wang J and Pantopoulos K. The pathway for IRP2 degradation involving 2-oxoglutarate-dependent oxygenase(s) does not require the E3 ubiquitin ligase activity of pVHL. Biochim Biophys Acta 1743: 79-85, 2005.
56. Wanner RM, Spielmann P, Stroka DM, Camenisch G, Camenisch I, Scheid A, Houck DR, Bauer C, Gassmann M, and Wenger RH. Epolones induce erythropoietin expression via hypoxia-inducible factor-1α activation. Blood 96: 1558-1565, 2000.
57. 2- regulated gene expression. FASEB J 16: 1151-1162, 2002.
58. Wenger RH, Stiehl DP, and Camenisch G. Integration of oxygen signaling at the consensus HRE. Sci STKE 2005: re12, 2005.
59. Yin L, Kharbanda S, and Kufe D. Mucin 1 oncoprotein blocks hypoxia-inducible factor 1α activation in a survival response to hypoxia. J Biol Chem 282: 257-266, 2007.
60. Zhou YD, Kim YP, Li XC, Baerson SR, Agarwal AK, Hodges TW, Ferreira D, and Nagle DG. Hypoxia-inducible factor-1 activation by (-)-epicatechin gallate: potential adverse effects of cancer chemoprevention with high-dose green tea extracts. J Nat Prod 67: 2063-2069, 2004.